
Maharashtra FDA revokes Cipla Pune warehouse licenses over misbranding
The story in brief
Maharashtra FDA revoked Cipla Pharma’s Pune warehouse licenses after finding misbranding on Reactin Plus tablets packaging. The Wadki warehouse faced storage lapses and documentation issues, prompting the Bombay High Court to order the revocation. Cipla was served a show-cause notice and must submit an explanation by September 11.